Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Geriatrics
Published in: BMC Geriatrics 1/2017

Open Access 01-12-2017 | Research Article

Concurrent use of alcohol interactive medications and alcohol in older adults: a systematic review of prevalence and associated adverse outcomes

Authors: Alice E. Holton, Paul Gallagher, Tom Fahey, Gráinne Cousins

Published in: BMC Geriatrics | Issue 1/2017

Login to get access

Abstract

Background

Older adults are susceptible to adverse effects from the concurrent use of medications and alcohol. The aim of this study was to systematically review the prevalence of concurrent use of alcohol and alcohol-interactive (AI) medicines in older adults and associated adverse outcomes.

Methods

A systematic search was performed using MEDLINE (PubMed), Embase, Scopus and Web of Science (January 1990 to June 2016), and hand searching references of retrieved articles. Observational studies reporting on the concurrent use of alcohol and AI medicines in the same or overlapping recall periods in older adults were included. Two independent reviewers verified that studies met the inclusion criteria, critically appraised included studies and extracted relevant data. A narrative synthesis is provided.

Results

Twenty studies, all cross-sectional, were included. Nine studies classified a wide range of medicines as AI using different medication compendia, thus resulting in heterogeneity across studies. Three studies investigated any medication use and eight focused on psychotropic medications. Based on the quality assessment of included studies, the most reliable estimate of concurrent use in older adults ranges between 21 and 35%. The most reliable estimate of concurrent use of psychotropic medications and alcohol ranges between 7.4 and 7.75%. No study examined longitudinal associations with adverse outcomes. Three cross-sectional studies reported on falls with mixed findings, while one study reported on the association between moderate alcohol consumption and adverse drug reactions at hospital admission.

Conclusions

While there appears to be a high propensity for alcohol-medication interactions in older adults, there is a lack of consensus regarding what constitutes an AI medication. An explicit list of AI medications needs to be derived and validated prospectively to quantify the magnitude of risk posed by the concurrent use of alcohol for adverse outcomes in older adults. This will allow for risk stratification of older adults at the point of prescribing, and prioritise alcohol screening and brief alcohol interventions in high-risk groups.
Appendix
Available only for authorised users
Literature
1.
United Nations, Department of Economic and Social Affairs PD. World Population Prospects: The 2015 Revision, Key Findings and Advance Tables. New York: 2015.
2.
Britton A, Ben-Shlomo Y, Benzeval M, Kuh D, Bell S. Life course trajectories of alcohol consumption in the United Kingdom using longitudinal data from nine cohort studies. BMC Med. 2015;13:47.CrossRefPubMedPubMedCentral
3.
Meng Y, Holmes J, Hill-McManus D, Brennan A, Meier PS. Trend analysis and modelling of gender-specific age, period and birth cohort effects on alcohol abstention and consumption level for drinkers in great Britain using the general lifestyle survey 1984–2009. Addiction. 2014;109
4.
5.
6.
NHS Information Centre: Statistics for Alcohol : England 2010. 2011.
7.
Office for National Statistics: 2010 Based Subnational Population Projections for England 2012.
8.
Hovstadius B, Hovstadius K, Astrand B, Petersson G. Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008. BMC Clin Pharmacol. 2010;10:16.CrossRefPubMedPubMedCentral
9.
Sumukadas D, McMurdo ME, Mangoni AA, Guthrie B. Temporal trends in anticholinergic medication prescription in older people: repeated cross-sectional analysis of population prescribing data. Age Ageing. 2014;43(4):515–21.CrossRefPubMed
10.
Richardson K, Moore P, Peklar J, Galvin R, Bennett K, RA. K. Polypharmacy in adults over 50 in Ireland: Opportunities for cost saving and improved healthcare. A report from The Irish Longitudinal Study on Ageing (TILDA). TILDA Trinity College Dublin 2012 December 2012. Report No.
11.
Moriarty F, Hardy C, Bennett K, Smith SM, Fahey T. Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study. BMJ Open. 2015;5(9):e008656.CrossRefPubMedPubMedCentral
12.
Weathermon R, Crabb DW. Alcohol and medication interactions. Alcohol Res Health. 1999;23(1):40–54.PubMed
13.
14.
Du Y, Scheidt-Nave C, Knopf H. Use of psychotropic drugs and alcohol among non-institutionalised elderly adults in Germany. Pharmacopsychiatry. 2008;41(6):242–51.CrossRefPubMed
15.
Ilomaki J, Paljarvi T, Korhonen MJ, Enlund H, Alderman CP, Kauhanen J, et al. Prevalence of concomitant use of alcohol and sedative-hypnotic drugs in middle and older aged persons: a systematic review. Ann Pharmacother. 2013;47(2):257–68.CrossRefPubMed
16.
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9. W64CrossRefPubMed
17.
Herzog R, Alvarez-Pasquin MJ, Diaz C, Del Barrio JL, Estrada JM, Gil A. Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health. 2013;13:154.CrossRefPubMedPubMedCentral
18.
Adams WL. Potential for adverse drug-alcohol interactions among retirement community residents. J Am Geriatr Soc. 1995;43(9):1021–5.CrossRefPubMed
19.
Aira M, Hartikainen S, Sulkava R. Community prevalence of alcohol use and concomitant use of medication - a source of possible risk in the elderly aged 75 and older? Int J Geriatr Psychiatry. 2005;20(7):680–5.CrossRefPubMed
20.
Breslow RA, Dong C, White A. Prevalence of alcohol-interactive prescription medication use among current drinkers: United States, 1999 to 2010. Alcohol Clin Exp Res. 2015;39(2):371–9.CrossRefPubMedPubMedCentral
21.
Cousins G, Galvin R, Flood M, Kennedy M-C, Motterlini N, Henman MC, et al. Potential for alcohol and drug interactions in older adults: evidence from the Irish longitudinal study on ageing. BMC Geriatr. 2014;14
22.
Del Rio MC, Prada C, Alvarez FJ. Do Spanish patients drink alcohol while undergoing treatment with benzodiazepines? Alcohol. 2002;26(1):31–4.CrossRefPubMed
23.
Del Río MC, Prada C, Alvarez FJ. The use of medication and alcohol among the Spanish population. Br J Clin Pharmacol. 1996;41(3):253–5.CrossRefPubMed
24.
Forster LE, Pollow R, Stoller EP. Alcohol use and potential risk for alcohol-related adverse drug reactions among community-based elderly. J Community Health. 1993;18(4):225–39.CrossRefPubMed
25.
Ilomaki J, Korhonen MJ, Enlund H, Hartzema AG, Kauhanen J. Risk drinking behavior among psychotropic drug users in an aging Finnish population: the FinDrink study. Alcohol. 2008;42(4):261–7.CrossRefPubMed
26.
Ilomaeki J, Gnjidic D, Hilmer SN, Le Couteur DG, Naganathan V, Cumming RG, et al. Psychotropic drug use and alcohol drinking in community-dwelling older Australian men: the CHAMP study. Drug Alcohol Review. 2013;32(2):218–22.CrossRef
27.
Immonen S, Pitkälä K. The prevalence of potential alcohol-drug interactions in older adults. Eur Geriatr Med. 2012;3:S134.CrossRef
28.
John U, Baumeister SE, Volzke H, Meyer C, Ulbricht S, Alte D. Sedative, hypnotic, anxiolytic and opioid medicament use and its co-occurrence with tobacco smoking and alcohol risk drinking in a community sample. BMC Public Health. 2007;7:337.CrossRefPubMedPubMedCentral
29.
Onder G, Landi F, Della Vedova C, Atkinson H, Pedone C, Cesari M, et al. Moderate alcohol consumption and adverse drug reactions among older adults. Pharmacoepidemiol Drug Safety. 2002;11(5):385–92.CrossRef
30.
Pringle KE, Ahern FM, Heller DA, Gold CH, Brown TV. Potential for alcohol and prescription drug interactions in older people. J Am Geriatr Soc. 2005;53(11):1930–6.CrossRefPubMed
31.
32.
Sheahan SL, Coons SJ, Robbins CA, Martin SS, Hendricks J, Latimer M. Psychoactive medication, alcohol use, and falls among older adults. J Behav Med. 1995;18(2):127–40.CrossRefPubMed
33.
Swift W, Stollznow N, Pirotta M. The use of alcohol and medicines among Australian adults. Aust N Z J Public Health. 2007;31(6):529–32.CrossRefPubMed
34.
Veldhuizen S, Wade TJ, Cairney J. Alcohol consumption among Canadians taking benzodiazepines and related drugs. Pharmacoepidemiol Drug Saf. 2009;18(3):203–10.CrossRefPubMed
35.
Wong H, Heuberger R, Logomarsino J, Hewlings S. Associations between alcohol use, polypharmacy and falls in older adults. Nurs Older People. 2016;28(1):30–6.PubMed
36.
Lagnaoui R, Moore N, Dartigues JF, Fourrier A, Begaud B. Benzodiazepine use and wine consumption in the French elderly. Br J Clin Pharmacol. 2001;52(4):455–6.CrossRefPubMedPubMedCentral
37.
Vitry AI. Comparative assessment of four drug interaction compendia. Br J Clin Pharmacol. 2007;63(6):709–14.CrossRefPubMed
38.
Brown J, West R, Angus C, Beard E, Brennan A, Drummond C, et al. Comparison of brief interventions in primary care on smoking and excessive alcohol consumption: a population survey in England. Br J Gen Pract. 2016;66(642):e1–9.CrossRefPubMed
39.
Hamilton FL, Laverty AA, Gluvajic D, Huckvale K, Car J, Majeed A, et al. Effect of financial incentives on delivery of alcohol screening and brief intervention (ASBI) in primary care: longitudinal study. J Public Health. 2014;36(3):450–9.CrossRef
40.
Deehan A, Templeton L, Taylor C, Drummond C, Strang J. Low detection rates, negative attitudes and the failure to meet the “health of the nation” alcohol targets: findings from a national survey of GPs in England and Wales. Drug Alcohol Rev. 1998;17(3):249–58.CrossRefPubMed
41.
Kaner EF, Beyer F, Dickinson HO, Pienaar E, Campbell F, Schlesinger C, et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev. 2007;2:CD004148.
42.
Benza AT, Calvert S, McQuown CB. Prevention BINGO: reducing medication and alcohol use risks for older adults. Aging Ment Health. 2010;14(8):1008–14.CrossRefPubMed
43.
National Consumers League (2013). Avoid Food Drug Interactions Food and Drug Administration Publication No. (FDA) CDER 10–1933.
44.
Alcoholism NIoAAa (2014). Harmful Interactions: mixing alcohol with medicines National Institutes of Health, US Department of Heath and Human Services 2014.
Metadata
Title
Concurrent use of alcohol interactive medications and alcohol in older adults: a systematic review of prevalence and associated adverse outcomes
Authors
Alice E. Holton
Paul Gallagher
Tom Fahey
Gráinne Cousins
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2017
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-017-0532-2

Other articles of this Issue 1/2017

BMC Geriatrics 1/2017 Go to the issue

Research Article

The impact of frailty on healthcare utilisation in Ireland: evidence from the Irish longitudinal study on ageing

Study protocol

Evaluation of a technology-enhanced integrated care model for frail older persons: protocol of the SPEC study, a stepped-wedge cluster randomized trial in nursing homes

Research Article

Can resources moderate the impact of levels of frailty on adverse outcomes among (pre-) frail older people? A longitudinal study

Research article

Managing multiple chronic conditions in the community: a Canadian qualitative study of the experiences of older adults, family caregivers and healthcare providers

Research article

Nutritional determinants of frailty in older adults: A systematic review

Research Article

Association of physical activity and appetite with visual function related to driving competence in older adults

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits